nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—Cardiac failure congestive—Liothyronine—hypothyroidism	0.0253	0.035	CcSEcCtD
Disopyramide—Abdominal bloating—Liotrix—hypothyroidism	0.0239	0.0332	CcSEcCtD
Disopyramide—Cyanosis—Liotrix—hypothyroidism	0.0161	0.0223	CcSEcCtD
Disopyramide—Feeling hot—Liotrix—hypothyroidism	0.0145	0.0201	CcSEcCtD
Disopyramide—Tingling sensation—Liotrix—hypothyroidism	0.0142	0.0197	CcSEcCtD
Disopyramide—Coma—Levothyroxine—hypothyroidism	0.0142	0.0196	CcSEcCtD
Disopyramide—Coma—Dextrothyroxine—hypothyroidism	0.0142	0.0196	CcSEcCtD
Disopyramide—Arrhythmia—Liothyronine—hypothyroidism	0.0142	0.0196	CcSEcCtD
Disopyramide—KCND2—heart—hypothyroidism	0.0136	0.0674	CbGeAlD
Disopyramide—KCND2—cardiovascular system—hypothyroidism	0.0129	0.0636	CbGeAlD
Disopyramide—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.0124	0.0172	CcSEcCtD
Disopyramide—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.0124	0.0172	CcSEcCtD
Disopyramide—Creatinine increased—Liotrix—hypothyroidism	0.012	0.0166	CcSEcCtD
Disopyramide—KCND3—heart—hypothyroidism	0.0119	0.0588	CbGeAlD
Disopyramide—Cardiac failure—Dextrothyroxine—hypothyroidism	0.0115	0.016	CcSEcCtD
Disopyramide—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.0115	0.016	CcSEcCtD
Disopyramide—Hypoglycaemia—Levothyroxine—hypothyroidism	0.0115	0.016	CcSEcCtD
Disopyramide—Cardiac failure—Levothyroxine—hypothyroidism	0.0115	0.016	CcSEcCtD
Disopyramide—KCND2—pituitary gland—hypothyroidism	0.0114	0.0563	CbGeAlD
Disopyramide—KCND3—cardiovascular system—hypothyroidism	0.0112	0.0554	CbGeAlD
Disopyramide—Blood urea increased—Liotrix—hypothyroidism	0.0108	0.0149	CcSEcCtD
Disopyramide—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.0107	0.0148	CcSEcCtD
Disopyramide—Cardiac arrest—Levothyroxine—hypothyroidism	0.0107	0.0148	CcSEcCtD
Disopyramide—CYP3A4—urine—hypothyroidism	0.0106	0.0525	CbGeAlD
Disopyramide—Hypotension—Liothyronine—hypothyroidism	0.0105	0.0146	CcSEcCtD
Disopyramide—Coma—Liotrix—hypothyroidism	0.0104	0.0144	CcSEcCtD
Disopyramide—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00992	0.0137	CcSEcCtD
Disopyramide—Muscular weakness—Levothyroxine—hypothyroidism	0.00992	0.0137	CcSEcCtD
Disopyramide—KCND2—female gonad—hypothyroidism	0.00948	0.0469	CbGeAlD
Disopyramide—Sweating increased—Dextrothyroxine—hypothyroidism	0.00947	0.0131	CcSEcCtD
Disopyramide—Sweating increased—Levothyroxine—hypothyroidism	0.00947	0.0131	CcSEcCtD
Disopyramide—Cardiac failure congestive—Liotrix—hypothyroidism	0.00912	0.0126	CcSEcCtD
Disopyramide—Body temperature increased—Liothyronine—hypothyroidism	0.0089	0.0123	CcSEcCtD
Disopyramide—KCND3—adrenal gland—hypothyroidism	0.00886	0.0439	CbGeAlD
Disopyramide—KCND3—thyroid gland—hypothyroidism	0.00855	0.0423	CbGeAlD
Disopyramide—Cardiac failure—Liotrix—hypothyroidism	0.00848	0.0118	CcSEcCtD
Disopyramide—Hypoglycaemia—Liotrix—hypothyroidism	0.00848	0.0118	CcSEcCtD
Disopyramide—KCND2—testis—hypothyroidism	0.00841	0.0416	CbGeAlD
Disopyramide—Cardiac arrest—Liotrix—hypothyroidism	0.00787	0.0109	CcSEcCtD
Disopyramide—KCND2—cerebellum—hypothyroidism	0.00776	0.0384	CbGeAlD
Disopyramide—Blood creatinine increased—Liotrix—hypothyroidism	0.00775	0.0107	CcSEcCtD
Disopyramide—Hypokalaemia—Liotrix—hypothyroidism	0.00753	0.0104	CcSEcCtD
Disopyramide—KCND3—testis—hypothyroidism	0.00733	0.0363	CbGeAlD
Disopyramide—Muscular weakness—Liotrix—hypothyroidism	0.0073	0.0101	CcSEcCtD
Disopyramide—Abdominal distension—Liotrix—hypothyroidism	0.0072	0.00998	CcSEcCtD
Disopyramide—SCN5A—heart—hypothyroidism	0.00713	0.0353	CbGeAlD
Disopyramide—Sweating increased—Liotrix—hypothyroidism	0.00696	0.00965	CcSEcCtD
Disopyramide—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00695	0.00963	CcSEcCtD
Disopyramide—Arrhythmia—Levothyroxine—hypothyroidism	0.00695	0.00963	CcSEcCtD
Disopyramide—KCND3—liver—hypothyroidism	0.00693	0.0343	CbGeAlD
Disopyramide—KCND3—cerebellum—hypothyroidism	0.00677	0.0335	CbGeAlD
Disopyramide—SCN5A—cardiovascular system—hypothyroidism	0.00673	0.0333	CbGeAlD
Disopyramide—Tension—Dextrothyroxine—hypothyroidism	0.00665	0.00921	CcSEcCtD
Disopyramide—Tension—Levothyroxine—hypothyroidism	0.00665	0.00921	CcSEcCtD
Disopyramide—Nervousness—Dextrothyroxine—hypothyroidism	0.00658	0.00912	CcSEcCtD
Disopyramide—Nervousness—Levothyroxine—hypothyroidism	0.00658	0.00912	CcSEcCtD
Disopyramide—Angioedema—Levothyroxine—hypothyroidism	0.00619	0.00858	CcSEcCtD
Disopyramide—Angioedema—Dextrothyroxine—hypothyroidism	0.00619	0.00858	CcSEcCtD
Disopyramide—CHRM2—heart—hypothyroidism	0.00607	0.03	CbGeAlD
Disopyramide—CHRM2—cardiovascular system—hypothyroidism	0.00573	0.0283	CbGeAlD
Disopyramide—Hypoaesthesia—Liotrix—hypothyroidism	0.00569	0.00789	CcSEcCtD
Disopyramide—Confusional state—Levothyroxine—hypothyroidism	0.00557	0.00773	CcSEcCtD
Disopyramide—Confusional state—Dextrothyroxine—hypothyroidism	0.00557	0.00773	CcSEcCtD
Disopyramide—Shock—Levothyroxine—hypothyroidism	0.00544	0.00754	CcSEcCtD
Disopyramide—Shock—Dextrothyroxine—hypothyroidism	0.00544	0.00754	CcSEcCtD
Disopyramide—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00534	0.00741	CcSEcCtD
Disopyramide—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00534	0.00741	CcSEcCtD
Disopyramide—SCN5A—blood—hypothyroidism	0.00532	0.0263	CbGeAlD
Disopyramide—CHRM1—cardiovascular system—hypothyroidism	0.00521	0.0258	CbGeAlD
Disopyramide—Arrhythmia—Liotrix—hypothyroidism	0.00511	0.00709	CcSEcCtD
Disopyramide—Insomnia—Dextrothyroxine—hypothyroidism	0.005	0.00693	CcSEcCtD
Disopyramide—Insomnia—Levothyroxine—hypothyroidism	0.005	0.00693	CcSEcCtD
Disopyramide—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00493	0.00683	CcSEcCtD
Disopyramide—Dyspnoea—Levothyroxine—hypothyroidism	0.00493	0.00683	CcSEcCtD
Disopyramide—Flatulence—Liotrix—hypothyroidism	0.00491	0.00681	CcSEcCtD
Disopyramide—Tension—Liotrix—hypothyroidism	0.00489	0.00678	CcSEcCtD
Disopyramide—Dysgeusia—Liotrix—hypothyroidism	0.00488	0.00676	CcSEcCtD
Disopyramide—ORM1—blood—hypothyroidism	0.00486	0.024	CbGeAlD
Disopyramide—Nervousness—Liotrix—hypothyroidism	0.00484	0.00671	CcSEcCtD
Disopyramide—Fatigue—Dextrothyroxine—hypothyroidism	0.00477	0.00661	CcSEcCtD
Disopyramide—Fatigue—Levothyroxine—hypothyroidism	0.00477	0.00661	CcSEcCtD
Disopyramide—Vision blurred—Liotrix—hypothyroidism	0.00469	0.00651	CcSEcCtD
Disopyramide—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00455	0.00631	CcSEcCtD
Disopyramide—Feeling abnormal—Levothyroxine—hypothyroidism	0.00455	0.00631	CcSEcCtD
Disopyramide—Angioedema—Liotrix—hypothyroidism	0.00455	0.00631	CcSEcCtD
Disopyramide—Syncope—Liotrix—hypothyroidism	0.00447	0.00619	CcSEcCtD
Disopyramide—SLC22A1—blood—hypothyroidism	0.00445	0.022	CbGeAlD
Disopyramide—Urticaria—Levothyroxine—hypothyroidism	0.00439	0.00609	CcSEcCtD
Disopyramide—Urticaria—Dextrothyroxine—hypothyroidism	0.00439	0.00609	CcSEcCtD
Disopyramide—Loss of consciousness—Liotrix—hypothyroidism	0.00438	0.00607	CcSEcCtD
Disopyramide—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00437	0.00606	CcSEcCtD
Disopyramide—Body temperature increased—Levothyroxine—hypothyroidism	0.00437	0.00606	CcSEcCtD
Disopyramide—Chest pain—Liotrix—hypothyroidism	0.00424	0.00588	CcSEcCtD
Disopyramide—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00419	0.0547	CbGpPWpGaD
Disopyramide—Confusional state—Liotrix—hypothyroidism	0.0041	0.00568	CcSEcCtD
Disopyramide—Oedema—Liotrix—hypothyroidism	0.00407	0.00564	CcSEcCtD
Disopyramide—Shock—Liotrix—hypothyroidism	0.004	0.00555	CcSEcCtD
Disopyramide—Asthenia—Levothyroxine—hypothyroidism	0.00397	0.0055	CcSEcCtD
Disopyramide—Asthenia—Dextrothyroxine—hypothyroidism	0.00397	0.0055	CcSEcCtD
Disopyramide—Hyperhidrosis—Liotrix—hypothyroidism	0.00393	0.00545	CcSEcCtD
Disopyramide—Pruritus—Dextrothyroxine—hypothyroidism	0.00391	0.00542	CcSEcCtD
Disopyramide—Pruritus—Levothyroxine—hypothyroidism	0.00391	0.00542	CcSEcCtD
Disopyramide—SLC22A1—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00391	0.051	CbGpPWpGaD
Disopyramide—Anorexia—Liotrix—hypothyroidism	0.00388	0.00537	CcSEcCtD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00384	0.0502	CbGpPWpGaD
Disopyramide—Hypotension—Liotrix—hypothyroidism	0.0038	0.00527	CcSEcCtD
Disopyramide—ORM1—liver—hypothyroidism	0.0038	0.0188	CbGeAlD
Disopyramide—Diarrhoea—Levothyroxine—hypothyroidism	0.00378	0.00524	CcSEcCtD
Disopyramide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00378	0.00524	CcSEcCtD
Disopyramide—Insomnia—Liotrix—hypothyroidism	0.00368	0.0051	CcSEcCtD
Disopyramide—Paraesthesia—Liotrix—hypothyroidism	0.00365	0.00506	CcSEcCtD
Disopyramide—Dyspnoea—Liotrix—hypothyroidism	0.00362	0.00502	CcSEcCtD
Disopyramide—CHRM3—thyroid gland—hypothyroidism	0.00356	0.0176	CbGeAlD
Disopyramide—Decreased appetite—Liotrix—hypothyroidism	0.00353	0.0049	CcSEcCtD
Disopyramide—Vomiting—Levothyroxine—hypothyroidism	0.00351	0.00487	CcSEcCtD
Disopyramide—Vomiting—Dextrothyroxine—hypothyroidism	0.00351	0.00487	CcSEcCtD
Disopyramide—Fatigue—Liotrix—hypothyroidism	0.00351	0.00486	CcSEcCtD
Disopyramide—Rash—Dextrothyroxine—hypothyroidism	0.00349	0.00483	CcSEcCtD
Disopyramide—Rash—Levothyroxine—hypothyroidism	0.00349	0.00483	CcSEcCtD
Disopyramide—Dermatitis—Dextrothyroxine—hypothyroidism	0.00348	0.00483	CcSEcCtD
Disopyramide—Dermatitis—Levothyroxine—hypothyroidism	0.00348	0.00483	CcSEcCtD
Disopyramide—SLC22A1—liver—hypothyroidism	0.00348	0.0172	CbGeAlD
Disopyramide—Constipation—Liotrix—hypothyroidism	0.00348	0.00482	CcSEcCtD
Disopyramide—Headache—Levothyroxine—hypothyroidism	0.00346	0.0048	CcSEcCtD
Disopyramide—Headache—Dextrothyroxine—hypothyroidism	0.00346	0.0048	CcSEcCtD
Disopyramide—CHRM3—female gonad—hypothyroidism	0.00344	0.017	CbGeAlD
Disopyramide—KCND3—Neuronal System—SLC5A7—hypothyroidism	0.00342	0.0447	CbGpPWpGaD
Disopyramide—Feeling abnormal—Liotrix—hypothyroidism	0.00335	0.00464	CcSEcCtD
Disopyramide—Nausea—Dextrothyroxine—hypothyroidism	0.00328	0.00455	CcSEcCtD
Disopyramide—Nausea—Levothyroxine—hypothyroidism	0.00328	0.00455	CcSEcCtD
Disopyramide—KCND2—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00328	0.0429	CbGpPWpGaD
Disopyramide—Urticaria—Liotrix—hypothyroidism	0.00323	0.00448	CcSEcCtD
Disopyramide—Body temperature increased—Liotrix—hypothyroidism	0.00321	0.00446	CcSEcCtD
Disopyramide—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.0032	0.0418	CbGpPWpGaD
Disopyramide—CHRM3—testis—hypothyroidism	0.00305	0.0151	CbGeAlD
Disopyramide—KCND2—Neuronal System—SLC5A7—hypothyroidism	0.00305	0.0398	CbGpPWpGaD
Disopyramide—SLC22A1—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00298	0.039	CbGpPWpGaD
Disopyramide—Asthenia—Liotrix—hypothyroidism	0.00292	0.00404	CcSEcCtD
Disopyramide—Pruritus—Liotrix—hypothyroidism	0.00288	0.00399	CcSEcCtD
Disopyramide—Diarrhoea—Liotrix—hypothyroidism	0.00278	0.00386	CcSEcCtD
Disopyramide—Dizziness—Liotrix—hypothyroidism	0.00269	0.00373	CcSEcCtD
Disopyramide—Vomiting—Liotrix—hypothyroidism	0.00259	0.00358	CcSEcCtD
Disopyramide—Rash—Liotrix—hypothyroidism	0.00256	0.00355	CcSEcCtD
Disopyramide—Dermatitis—Liotrix—hypothyroidism	0.00256	0.00355	CcSEcCtD
Disopyramide—Headache—Liotrix—hypothyroidism	0.00255	0.00353	CcSEcCtD
Disopyramide—Nausea—Liotrix—hypothyroidism	0.00241	0.00335	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00227	0.0297	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—NEFL—hypothyroidism	0.0022	0.0288	CbGpPWpGaD
Disopyramide—CYP3A4—blood—hypothyroidism	0.00203	0.01	CbGeAlD
Disopyramide—KCND2—Neuronal System—NEFL—hypothyroidism	0.00196	0.0256	CbGpPWpGaD
Disopyramide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00164	0.0214	CbGpPWpGaD
Disopyramide—CYP3A4—liver—hypothyroidism	0.00159	0.00784	CbGeAlD
Disopyramide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00153	0.02	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00146	0.0191	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—AVP—hypothyroidism	0.00125	0.0163	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00117	0.0153	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000919	0.012	CbGpPWpGaD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.000884	0.0115	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000856	0.0112	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000755	0.00987	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000745	0.00973	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—CLTC—hypothyroidism	0.000716	0.00935	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.000704	0.00919	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000694	0.00907	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—SLC5A7—hypothyroidism	0.000656	0.00857	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000655	0.00855	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000617	0.00806	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000592	0.00773	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000583	0.00761	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000575	0.00751	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000552	0.00721	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—CLTC—hypothyroidism	0.000511	0.00667	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—TRH—hypothyroidism	0.000502	0.00655	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—TRH—hypothyroidism	0.0005	0.00653	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000478	0.00624	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000476	0.00622	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000472	0.00616	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.000454	0.00592	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000449	0.00586	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000447	0.00584	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—NEFL—hypothyroidism	0.000423	0.00552	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000378	0.00494	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000353	0.00461	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—VAV3—hypothyroidism	0.000337	0.0044	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000332	0.00434	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000331	0.00433	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000328	0.00428	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000314	0.0041	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000301	0.00393	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000298	0.00389	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000296	0.00387	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000296	0.00387	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000295	0.00385	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000295	0.00385	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000292	0.00382	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000292	0.00382	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000292	0.00382	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000277	0.00362	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—AVP—hypothyroidism	0.000263	0.00344	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—AVP—hypothyroidism	0.000263	0.00343	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—IYD—hypothyroidism	0.000256	0.00334	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—TRH—hypothyroidism	0.000253	0.0033	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—TRH—hypothyroidism	0.000252	0.00329	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—TRH—hypothyroidism	0.00025	0.00326	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—AVP—hypothyroidism	0.000249	0.00325	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—VAV3—hypothyroidism	0.000241	0.00314	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—IYD—hypothyroidism	0.000238	0.00311	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000236	0.00308	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000235	0.00307	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000234	0.00306	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000225	0.00294	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000225	0.00294	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—TSHB—hypothyroidism	0.000225	0.00294	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—TSHR—hypothyroidism	0.000225	0.00294	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	0.000223	0.00291	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	0.000223	0.00291	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—IYD—hypothyroidism	0.00022	0.00288	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000218	0.00285	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.000217	0.00284	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TPO—hypothyroidism	0.000204	0.00267	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ATP5O—hypothyroidism	0.000203	0.00265	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TPO—hypothyroidism	0.000191	0.00249	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ATP5O—hypothyroidism	0.000187	0.00245	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TPO—hypothyroidism	0.000176	0.0023	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000174	0.00228	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000174	0.00227	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000172	0.00225	CbGpPWpGaD
Disopyramide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000169	0.00221	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000151	0.00198	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000144	0.00188	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—TRH—hypothyroidism	0.000143	0.00187	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—TRH—hypothyroidism	0.000142	0.00186	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000141	0.00184	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000141	0.00184	CbGpPWpGaD
Disopyramide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000137	0.00179	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—AVP—hypothyroidism	0.000133	0.00174	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—AVP—hypothyroidism	0.000132	0.00173	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.000131	0.00171	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—TRH—hypothyroidism	0.00013	0.0017	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—TRH—hypothyroidism	0.000129	0.00169	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.000128	0.00167	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000127	0.00166	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000127	0.00166	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—TSHB—hypothyroidism	0.000127	0.00166	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—TSHR—hypothyroidism	0.000127	0.00166	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000126	0.00164	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000126	0.00164	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000119	0.00156	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000116	0.00151	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000116	0.00151	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000116	0.00151	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000116	0.00151	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—TSHB—hypothyroidism	0.000115	0.00151	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—TSHR—hypothyroidism	0.000115	0.00151	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000114	0.0015	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.000114	0.00149	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.000114	0.00149	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000111	0.00145	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TSHB—hypothyroidism	9.46e-05	0.00124	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CLTC—hypothyroidism	8.87e-05	0.00116	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CLTC—hypothyroidism	8.84e-05	0.00116	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—POMC—hypothyroidism	8.83e-05	0.00115	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TSHB—hypothyroidism	8.82e-05	0.00115	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—POMC—hypothyroidism	8.8e-05	0.00115	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CLTC—hypothyroidism	8.76e-05	0.00114	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—POMC—hypothyroidism	8.72e-05	0.00114	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—IYD—hypothyroidism	8.61e-05	0.00112	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	8.43e-05	0.0011	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TSHB—hypothyroidism	8.15e-05	0.00106	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	7.86e-05	0.00103	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	7.79e-05	0.00102	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—VAV3—hypothyroidism	7.77e-05	0.00101	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	7.69e-05	0.001	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TRH—hypothyroidism	7.67e-05	0.001	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TRH—hypothyroidism	7.64e-05	0.000998	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TRH—hypothyroidism	7.57e-05	0.000989	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	7.51e-05	0.000981	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AVP—hypothyroidism	7.48e-05	0.000978	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	7.41e-05	0.000968	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.32e-05	0.000956	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.29e-05	0.000953	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3C2A—hypothyroidism	7.26e-05	0.000949	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SLC5A5—hypothyroidism	7.08e-05	0.000925	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	7.08e-05	0.000924	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—VAV3—hypothyroidism	7.05e-05	0.000922	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	6.99e-05	0.000913	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TPO—hypothyroidism	6.88e-05	0.000899	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TSHB—hypothyroidism	6.83e-05	0.000893	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TSHR—hypothyroidism	6.83e-05	0.000893	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AVP—hypothyroidism	6.82e-05	0.000891	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TSHB—hypothyroidism	6.81e-05	0.00089	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TSHR—hypothyroidism	6.81e-05	0.00089	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AVP—hypothyroidism	6.8e-05	0.000888	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TSHB—hypothyroidism	6.75e-05	0.000881	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TSHR—hypothyroidism	6.75e-05	0.000881	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AVP—hypothyroidism	6.73e-05	0.000879	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SLC5A5—hypothyroidism	6.6e-05	0.000862	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SLC5A5—hypothyroidism	6.1e-05	0.000797	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	6.09e-05	0.000796	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SH2B3—hypothyroidism	6.07e-05	0.000793	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	6.01e-05	0.000785	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	4.99e-05	0.000652	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—POMC—hypothyroidism	4.97e-05	0.00065	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	4.93e-05	0.000643	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—POMC—hypothyroidism	4.53e-05	0.000592	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRL—hypothyroidism	4.52e-05	0.00059	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—POMC—hypothyroidism	4.52e-05	0.00059	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRL—hypothyroidism	4.5e-05	0.000588	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—POMC—hypothyroidism	4.47e-05	0.000584	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRL—hypothyroidism	4.46e-05	0.000583	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VAV3—hypothyroidism	4.18e-05	0.000546	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VAV3—hypothyroidism	4.17e-05	0.000544	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VAV3—hypothyroidism	4.13e-05	0.000539	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AVP—hypothyroidism	4.03e-05	0.000526	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AVP—hypothyroidism	4.02e-05	0.000524	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AVP—hypothyroidism	3.98e-05	0.000519	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—POMC—hypothyroidism	3.71e-05	0.000484	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—POMC—hypothyroidism	3.45e-05	0.000451	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—POMC—hypothyroidism	3.19e-05	0.000417	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TSHB—hypothyroidism	3.19e-05	0.000416	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.84e-05	0.000371	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—POMC—hypothyroidism	2.68e-05	0.00035	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—POMC—hypothyroidism	2.67e-05	0.000349	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—POMC—hypothyroidism	2.64e-05	0.000345	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1—hypothyroidism	2.57e-05	0.000336	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1—hypothyroidism	2.57e-05	0.000335	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1—hypothyroidism	2.54e-05	0.000332	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.38e-05	0.000311	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—POMC—hypothyroidism	1.25e-05	0.000163	CbGpPWpGaD
